Literature DB >> 7827240

Multiple myeloma among blacks and whites in the United States: the role of chronic antigenic stimulation.

D R Lewis1, L M Pottern, L M Brown, D T Silverman, R B Hayes, J B Schoenberg, R S Greenberg, G M Swanson, A G Schwartz, J M Liff.   

Abstract

Multiple myeloma (MM) is twice as common among Blacks than Whites in the United States. The reasons for this racial disparity are unknown, and the etiology of this cancer, in general, is poorly understood. Repeated or chronic antigenic stimulation (CAS) of the immune system has been suggested as a risk factor. Previous case-control studies have reported inconsistent CAS associations based on evaluations of individual and biologic categories of medical conditions. Interview data from 573 cases and 2,131 population-based controls were used to investigate further the CAS hypothesis using an immunologically based approach, and to determine whether CAS accounts for the excess of myeloma among Blacks. Over 50 medical conditions were grouped into biologically and immunologically related categories, and B-cell- and T-cell-mediated response groups. Except for urinary tract infections among Black men (odds ratio [OR] = 2.0), no significantly increased risks of MM were observed. However, there was a suggestion of increased risk among Blacks with an increased exposure to anaphylactic conditions. Analysis by immunoglobulin type revealed significantly elevated risks of IgG myeloma with eczema (OR = 2.1), the biologic category 'allergic conditions' (OR = 1.6), and the immunologic category 'anaphylaxis response' (OR = 1.6) among Whites, with Blacks having slightly lower risks. Our findings do not support a causal relationship between CAS and MM, nor do they explain the higher incidence among Blacks.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7827240     DOI: 10.1007/bf01831381

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  22 in total

1.  Leukemia and auto-immunization- some possible relationships.

Authors:  W DAMESHEK; R S SCHWARTZ
Journal:  Blood       Date:  1959-10       Impact factor: 22.113

2.  A case-control study of multiple myeloma nested in the American Cancer Society prospective study.

Authors:  P Boffetta; S D Stellman; L Garfinkel
Journal:  Int J Cancer       Date:  1989-04-15       Impact factor: 7.396

3.  Plasmacytomas in mice.

Authors:  M Potter
Journal:  Semin Oncol       Date:  1986-09       Impact factor: 4.929

4.  Multiple myeloma associated with long history of hyposensitisation with allergen vaccines.

Authors:  A J Woodroffe
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

5.  Repeated stimulation of the reticuloendothelial system and the development of plasma-cell dyscrasias.

Authors:  R Penny; S Hughes
Journal:  Lancet       Date:  1970-01-10       Impact factor: 79.321

6.  Multiple myeloma and prolonged stimulation of reticuloendothelial system.

Authors:  S Imahori; G E Moore
Journal:  N Y State J Med       Date:  1972-06-15

7.  Epidemiology of the M-component immunoglobulin types of multiple myeloma.

Authors:  L J Herrinton; P A Demers; T D Koepsell; N S Weiss; J R Daling; J W Taylor; J L Lyon; G M Swanson; R S Greenberg
Journal:  Cancer Causes Control       Date:  1993-03       Impact factor: 2.506

8.  Antigenic stimulation and the occurrence of multiple myeloma.

Authors:  T D Koepsell; J R Daling; N S Weiss; J W Taylor; A F Olshan; J L Lyon; G M Swanson; M Child
Journal:  Am J Epidemiol       Date:  1987-12       Impact factor: 4.897

9.  Medical history and the risk of multiple myeloma.

Authors:  A Gramenzi; I Buttino; B D'Avanzo; E Negri; S Franceschi; C La Vecchia
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

10.  Multiple myeloma--a case-control study.

Authors:  J Cuzick; B De Stavola
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640

View more
  9 in total

1.  Socioeconomic status and multiple myeloma among US blacks and whites.

Authors:  D Baris; L M Brown; D T Silverman; R Hayes; R N Hoover; G M Swanson; M Dosemeci; A G Schwartz; J M Liff; J B Schoenberg; L M Pottern; J Lubin; R S Greenberg; J F Fraumeni
Journal:  Am J Public Health       Date:  2000-08       Impact factor: 9.308

2.  Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic.

Authors:  Ingemar Turesson; Ramon Velez; Sigurdur Y Kristinsson; Ola Landgren
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

3.  Potential Correlation Between Eczema and Hematological Malignancies Risk: A Systematic Review and Meta-Analysis.

Authors:  Zuohui Liang; Jie Liu; Hongxia Jin; Yirong Teng; Shuangyan Xu; Weimin Yan; Yun Zhu
Journal:  Front Med (Lausanne)       Date:  2022-06-29

4.  Multiple genetic loci modify susceptibility to plasmacytoma-related morbidity in E(mu)-v-abl transgenic mice.

Authors:  R C Andrew Symons; Mark J Daly; Jane Fridlyand; Terence P Speed; Wendy D Cook; Steven Gerondakis; Alan W Harris; Simon J Foote
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-30       Impact factor: 11.205

5.  Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.

Authors:  Linda Morris Brown; Gloria Gridley; David Check; Ola Landgren
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

6.  Noncutaneous and Cutaneous Cancer Risk in Patients With Atopic Dermatitis: A Systematic Review and Meta-analysis.

Authors:  Lily Wang; Rachel Bierbrier; Aaron M Drucker; An-Wen Chan
Journal:  JAMA Dermatol       Date:  2020-02-01       Impact factor: 10.282

Review 7.  Differences in cancer incidence, mortality, and survival between African Americans and whites.

Authors:  B Walker; L W Figgs; S H Zahm
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

8.  Multiple myeloma and atopic eczema in an adult.

Authors:  Mohammad Amir Hossain; Qiang Nai; Ping Zhang; Hongxiu Luo; Mohammed Amzad Hossain; Abdul Mahmad; Abdalla M Yousif; Shuvendu Sen
Journal:  Case Rep Oncol       Date:  2015-02-06

9.  Risk of multiple myeloma in rheumatoid arthritis: a meta-analysis of case-control and cohort studies.

Authors:  Kaini Shen; Gufeng Xu; Qing Wu; Daobin Zhou; Jian Li
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.